Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model

Laure Chaput, Victoria Grèze, Pascale Halle, Nina Radosevic-Robin, Bruno Pereira, Lauren Véronèse, Hervé Lejeune, Philippe Durand, Guillaume Martin, Sandra Sanfilippo, Michel Canis, Justyna Kanold, Andrei Tchirkov, Florence Brugnon, Laure Chaput, Victoria Grèze, Pascale Halle, Nina Radosevic-Robin, Bruno Pereira, Lauren Véronèse, Hervé Lejeune, Philippe Durand, Guillaume Martin, Sandra Sanfilippo, Michel Canis, Justyna Kanold, Andrei Tchirkov, Florence Brugnon

Abstract

Ewing sarcoma (EWS) is a common pediatric solid tumor with high metastatic potential. Due to toxic effects of treatments on reproductive functions, the cryopreservation of ovarian tissue (OT) or testicular tissue (TT) is recommended to preserve fertility. However, the risk of reintroducing residual metastatic tumor cells should be evaluated before fertility restoration. Our goal was to validate a sensitive and specific approach for EWS minimal residual disease (MRD) detection in frozen germinal tissues. Thawed OT (n = 12) and TT (n = 14) were contaminated with tumor RD-ES cells (10, 100, and 1000 cells) and EWS-FLI1 tumor-specific transcript was quantified with RT-qPCR. All contaminated samples were found to be positive, with a strong correlation between RD-ES cell numbers and EWS-FLI1 levels in OT (r = 0.93) and TT (r = 0.96) (p < 0.001). No transcript was detected in uncontaminated control samples. The invasive potential of Ewing cells was evaluated using co-culture techniques. After co-culturing, tumor cells were detected in OT/TT with histology, FISH, and RT-qPCR. In addition, four OT and four TT samples from children with metastatic EWS were tested, and no MRD was found using RT-qPCR and histology. We demonstrated the high sensitivity and specificity of RT-qPCR to detect EWS MRD in OT/TT samples. Clinical trial: NCT02400970.

Keywords: Ewing sarcoma; RT-qPCR; fertility preservation; minimal residual disease detection; ovarian tissue; testicular tissue.

Conflict of interest statement

The authors declare they have no conflict of interest.

Figures

Figure 1
Figure 1
Ewing sarcoma (EWS)-FLI1 transcripts detection in ovarian tissue (n = 12). Relative quantification of EWS-FLI1 transcripts (B2M reference gene) for the contamination with 0, 10, 100 and 1000 cells. Each symbol represents one ovarian fragment (the average of the duplicates for 1000 cells or triplicates for 10 and 100 cells). The symbol ** means there was a significant difference and p < 0.001.
Figure 2
Figure 2
EWS-FLI1 transcripts detection in testicular tissue (n = 14). Relative quantification of EWS-FLI1 transcripts (B2M reference gene) for the contamination with 0, 10, 100, and 1000 cells. Each symbol represents one testicular fragment (the average of the duplicates for 1000 cells or triplicates for 10 and 100 cells). The symbol ** means there was a significant difference and p < 0.001.
Figure 3
Figure 3
Sensitivity (SE) and specificity (SP) of detection to distinguish 10 and 100 Ewing cells, and 100 and 1000 Ewing cells in ovarian tissue: (a) The AUC (area under the curve, ROC curve) was 0.94 CI 95% [0.86–1.00] to distinguish 10 and 100 Ewing cells. The optimal decision threshold, determined using Liu and Youden indexes, to distinguish between 10 and 100 EWS cells was 354 EWS-FLI1 transcripts with a sensitivity (SE) of 95% and a specificity (SP) of 86% (in red). For maximal SE (100%) and SP (100%), the cut-offs were 319 and 1150 EWS-FLI1 transcripts, respectively. (b) The area under the curve (AUC) was 0.97 CI 95% [0.92–1.00] between 100 and 1000 Ewing cells. To distinguish between 100 and 1000 EWS cells, the optimal decision threshold determined using Liu and Youden indexes was 3998 EWS-FLI1 transcripts with a SE of 100% and SP of 86% (in red). For a maximal SP (100%), the cut-off was 5528 EWS-FLI1 transcripts.
Figure 4
Figure 4
Sensitivity and specificity of detection to distinguish 10 and 100 EWS cells, and 100 and 1000 EWS cells in testicular tissue: (a) The AUC was 0.98 CI 95% [0.94–1.00] to characterize 10 and 100 EWS cells. The thresholds to distinguish between 10 and 100 EWS cells were 642 EWS-FLI1 transcripts (Liu and Youden indexes, SE = 92% and SP = 95%) (in red), 521 EWS-FLI1 transcripts for SE = 100% and 749 EWS-FLI1 transcripts for SP = 100%. (b) The AUC was 0.99 CI 95% [0.98–1.00] between 100 and 1000 EWS cells. The cut-offs to distinguish between 100 and 1000 EWS were 3172 EWS-FLI1 transcripts (Liu and Youden indexes, SE = 93% and SP = 100%) (in red) and 2170 EWS-FLI1 transcripts for SE = 100%.
Figure 5
Figure 5
Illustrations of histology: ovarian tissue (OT) after co-culture with RD-ES cells (at day 7); (a) RD-ES cells (arrow) localized in OT after co-culture stained with hematoxylin and eosin (×10); (b) Area with RD-ES cells disseminated in OT (×20); (c) Area with ovarian follicle (×20).
Figure 5
Figure 5
Illustrations of histology: ovarian tissue (OT) after co-culture with RD-ES cells (at day 7); (a) RD-ES cells (arrow) localized in OT after co-culture stained with hematoxylin and eosin (×10); (b) Area with RD-ES cells disseminated in OT (×20); (c) Area with ovarian follicle (×20).
Figure 6
Figure 6
Illustrations of histology and immunohistochemistry: RD-ES cells (black arrow) localized in testicular tissue (TT) after co-culture (at day 14) on insert; (a) TT in insert stained with hematoxylin and eosin (×20); (b) ERG-positive staining of RD-ES cells (×20).
Figure 7
Figure 7
Fluorescence in situ hybridization (FISH) analysis of ovarian tissue using EWSR1 (22q12) dual color break apart rearrangement probe (Vysis) showing RD-ES cells invasion (white arrows) after co-culture (at day 14) (×80). RD-ES cells displayed one fusion (yellow signal), and the simultaneous split pattern of one orange and one green signal (arrows), indicative of a rearrangement of one copy of the EWSR1 gene. The fusion gene is detected by a yellow signal, corresponding to co-localization of the red and green probes.

References

    1. Dolmans M.M., Iwahara Y., Donnez J., Soares M., Vaerman J.L., Amorim C.A., Poirel H. Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients. Hum. Reprod. 2016;31:2292–2302. doi: 10.1093/humrep/dew193.
    1. Ludwig J.A. Ewing sarcoma: Historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr. Opin. Oncol. 2008;20:412–418. doi: 10.1097/CCO.0b013e328303ba1d.
    1. Sullivan H.C., Shulman S.C., Olson T., Ricketts R., Oskouei S., Shehata B.M. Unusual presentation of metastatic Ewing sarcoma to the ovary in a 13 year-old: A case report and review. Fetal Pediatr. Pathol. 2012;31:159–163. doi: 10.3109/15513815.2012.659379.
    1. Machado I., Navarro S., Llombart-Bosch A. Ewing sarcoma and the new emerging Ewing-like sarcomas: (CIC and BCOR-rearranged-sarcomas). A systematic review. Histol. Histopathol. 2016;31:1169–1181.
    1. Chaturvedi A., Hoffman L.M., Jensen C.C., Lin Y.-C., Grossmann A.H., Randall R.L., Lessnick S.L., Welm A.L., Beckerle M.C. Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma. Mol. Biol. Cell. 2014;25:2695–2709. doi: 10.1091/mbc.e14-01-0007.
    1. Schleiermacher G., Peter M., Oberlin O., Philip T., Rubie H., Mechinaud F., Sommelet-Olive D., Landman-Parker J., Bours D., Michon J., et al. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor. J. Clin. Oncol. 2003;21:85–91. doi: 10.1200/JCO.2003.03.006.
    1. Sonmezer M., Shamonki M.I., Oktay K. Ovarian tissue cryopreservation: Benefits and risks. Cell Tissue Res. 2005;322:125–132. doi: 10.1007/s00441-005-1098-4.
    1. Raciborska A., Bilska K., Filipp E., Drabko K., Rogowska E., Chaber R., Pogorzała M., Połczyńska K., Adrianowska N., Rodriguez-Galindo C., et al. Ovarian function in female survivors after multimodal Ewing sarcoma therapy. Pediatr. Blood Cancer. 2015;62:341–345. doi: 10.1002/pbc.25304.
    1. Ginsberg J.P., Carlson C.A., Lin K., Hobbie W.L., Wigo E., Wu X., Brinster R.L., Kolon T.F. An experimental protocol for fertility preservation in prepubertal boys recently diagnosed with cancer: A report of acceptability and safety. Hum. Reprod. 2010;25:37–41. doi: 10.1093/humrep/dep371.
    1. Jensen A.K., Macklon K.T., Fedder J., Ernst E., Humaidan P., Andersen C.Y. Erratum to: 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: Focus on birth and perinatal outcome in 40 of these children. J. Assist. Reprod. Genet. 2017;34:337. doi: 10.1007/s10815-017-0873-y.
    1. Fayomi A.P., Peters K., Sukhwani M., Valli-Pulaski H., Shetty G., Meistrich M.L., Houser L., Robertson N., Roberts V., Ramsey C., et al. Autologous grafting of cryopreserved prepubertal rhesus testis produces sperm and offspring. Science. 2019;363:1314–1319. doi: 10.1126/science.aav2914.
    1. Perrard M.-H., Sereni N., Schluth-Bolard C., Blondet A., d’Estaing S.G., Plotton I., Morel-Journel N., Lejeune H., David L., Durand P. Complete Human and Rat Ex Vivo Spermatogenesis from Fresh or Frozen Testicular Tissue. Biol. Reprod. 2016;95:89. doi: 10.1095/biolreprod.116.142802.
    1. Vermeulen J., Ballet S., Oberlin O., Peter M., Pierron G., Longavenne E., Laurence V., Kanold J., Chastagner P., Lejars O., et al. Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour. Br. J. Cancer. 2006;95:1326–1333. doi: 10.1038/sj.bjc.6603438.
    1. Schifflers S., Delbecque K., Galant C., Francotte N., Philippet P., Chantrain C.F. Microscopic Infiltration of Cryopreserved Ovarian Tissue in 2 Patients With Ewing Sarcoma. J. Pediatr. Hematol. Oncol. 2018;40:e167–e170. doi: 10.1097/MPH.0000000000000928.
    1. Abir R., Feinmesser M., Yaniv I., Fisch B., Cohen I.J., Ben-Haroush A., Meirow D., Felz C., Avigad S. Occasional involvement of the ovary in Ewing sarcoma. Hum. Reprod. 2010;25:1708–1712. doi: 10.1093/humrep/deq121.
    1. Greve T., Wielenga V.T., Grauslund M., Sørensen N., Christiansen D.B., Rosendahl M., Yding Andersen C. Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination. Eur. J. Cancer. 2013;49:1932–1938. doi: 10.1016/j.ejca.2013.01.032.
    1. Wallace W.H.B., Anderson R.A., Irvine D.S. Fertility preservation for young patients with cancer: Who is at risk and what can be offered? Lancet Oncol. 2005;6:209–218. doi: 10.1016/S1470-2045(05)70092-9.
    1. Andersen C.Y., Rosendahl M., Byskov A.G., Loft A., Ottosen C., Dueholm M., Schmidt K.L.T., Andersen A.N., Ernst E. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum. Reprod. 2008;23:2266–2272. doi: 10.1093/humrep/den244.
    1. Ernst E., Bergholdt S., Jørgensen J.S., Andersen C.Y. The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue. Hum. Reprod. 2010;25:1280–1281. doi: 10.1093/humrep/deq033.
    1. Andersen C.Y., Silber S.J., Bergholdt S.H., Berghold S.H., Jorgensen J.S., Ernst E. Long-term duration of function of ovarian tissue transplants: Case reports. Reprod. Biomed. Online. 2012;25:128–132. doi: 10.1016/j.rbmo.2012.03.014.
    1. Delattre O., Zucman J., Melot T., Garau X., Zucker J., Lenoir G., Ambros P., Sheer D., Turc-Carel C., Triche T. The Ewing Family of Tumors—A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts. N. Engl. J. Med. 1994;331:294–299. doi: 10.1056/NEJM199408043310503.
    1. Lewis T.B., Coffin C.M., Bernard P.S. Differentiating Ewing’s sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues. Mod. Pathol. 2007;20:397–404. doi: 10.1038/modpathol.3800755.
    1. Bridge R.S., Rajaram V., Dehner L.P., Pfeifer J.D., Perry A. Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: A comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod. Pathol. 2006;19:1–8. doi: 10.1038/modpathol.3800486.
    1. Young R.H., Kozakewich H.P., Scully R.E. Metastatic ovarian tumors in children: A report of 14 cases and review of the literature. Int. J. Gynecol. Pathol. 1993;12:8–19. doi: 10.1097/00004347-199301000-00002.
    1. Sørensen S.D., Greve T., Wielenga V.T., Wallace W.H.B., Andersen C.Y. Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing’s sarcoma. Future Oncol. 2014;10:277–283. doi: 10.2217/fon.13.183.
    1. O’Brien M.J., Pendola J.K., Eppig J.J. A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence. Biol. Reprod. 2003;68:1682–1686. doi: 10.1095/biolreprod.102.013029.
    1. Xu M., Fazleabas A.T., Shikanov A., Jackson E., Barrett S.L., Hirshfeld-Cytron J., Kiesewetter S.E., Shea L.D., Woodruff T.K. In vitro oocyte maturation and preantral follicle culture from the luteal-phase baboon ovary produce mature oocytes. Biol. Reprod. 2011;84:689–697. doi: 10.1095/biolreprod.110.088674.
    1. Sanfilippo S., Canis M., Romero S., Sion B., Déchelotte P., Pouly J.-L., Janny L., Smitz J., Brugnon F. Quality and functionality of human ovarian tissue after cryopreservation using an original slow freezing procedure. J. Assist. Reprod. Genet. 2013;30:25–34. doi: 10.1007/s10815-012-9917-5.
    1. Rives N., Milazzo J.-P., Travers A., Arkoun B., Bironneau A., Sibert L., Liard-Zmuda A., Marie-Cardine A., Schneider P., Vannier J.-P., et al. [Cryopreservation of testicular tissue in children] Bull. Acad. Natl. Med. 2013;197:877–886.
    1. Ke C., Duan Q., Yang H., Zhu F., Yan M., Xu S.-P., Zhou S., Wan F., Shu K., Lei T., et al. Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases. Neuropathology. 2017;37:35–44. doi: 10.1111/neup.12325.

Source: PubMed

3
Subskrybuj